As you are aware, Slantrange was acquired by Hiphen last May, and since then, our primary focus has been on ensuring a seamless transition for Slantrange clients to Hiphen, providing the best possible experience throughout the process.

With this transition in mind, we would like to inform you that the Slantview data platform will be discontinued. Instead, all data processing action and results will now be delivered through Cloverfield, Hiphen's homegrown data platform. This decision has been made in the interest of practicality and to offer our clients the best user experience.

The merging of Slantrange and Hiphen platforms has been a comprehensive process, allowing us to draw on the strengths of both. The insights gained from this integration have been instrumental in enhancing Cloverfield, making it an all-in-one online platform that you can trust for your phenotyping needs.



We understand that change can be challenging, but we believe that this transition will bring the best of both worlds to our clients. The improvements made to Cloverfield™, based on the lessons learned from the comparison of both platforms, will undoubtedly elevate your phenotyping experience.

This decision also aligns with our upcoming strategic developments at Hiphen. We are committed to maximizing your phenotyping experience by implementing improvements in internal tools, enhancing interconnectivity, ensuring transparency, and prioritizing data security. These developments are part of our broader strategy to provide you with a cutting-edge platform that meets and exceeds your expectations.

We appreciate your understanding and cooperation during this transition. If you have any questions or concerns, please do not hesitate to reach out to our Success Team using the button below.

We are dedicated to making this transition as smooth as possible for you. Thank you for your trust in Hiphen.

Your Hiphen Success Team.